XML 31 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Held-For-Sale Classification
9 Months Ended
Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Held-For-Sale Classification
4. Held-For-Sale Classification
HELD-FOR-SALE CLASSIFICATION
We report and classify a business as held-for-sale (Held-For-Sale Business) when management has approved the sale or received approval to sell the business and is committed to a formal plan, the business is available for immediate sale, the business is being actively marketed, the sale is anticipated to occur during the next 12 months and certain other specified criteria are met. A Held-For-Sale Business is recorded at the lower of its carrying amount or estimated fair value less cost to sell. If the carrying amount of the business exceeds its estimated fair value, a loss is recognized.
Assets and liabilities related to a Held-For-Sale Business are reported in Assets held for sale and Liabilities held for sale, respectively, in our Condensed Consolidated Balance Sheets beginning in the period in which the business is classified as held-for-sale. At September 30, 2023, the following business was reported and classified as held-for-sale:
Validus Re
To further simplify AIG's business model and reduce volatility in our portfolio, on May 22, 2023, AIG announced that it entered into a definitive agreement to sell Validus Re, including AlphaCat Managers Ltd. and the Talbot Treaty reinsurance business to RenaissanceRe for $2.7 billion in cash and approximately 1.3 million common shares of RenaissanceRe. Additionally, AIG agreed to retain 95 percent of the difference between (i) the reserves with respect to the business as of the closing date of the sale for losses occurring prior to the closing date and (ii) the associated reserve development following the closing date with respect to such losses. Any reserve development will be settled annually, commencing with the calendar year ending December 31, 2024. This arrangement stays in effect until the parties determine to terminate such arrangement (which they will re-evaluate on an annual basis beginning 5 years after the closing date) or until all such liabilities of the acquired reinsurance business have run off. This reserve cover is considered contingent consideration and will be recognized at fair value when the sale of Validus Re closes.
On September 4, 2023, AIG entered into an Adverse Development Cover Excess of Loss Agreement (the ADC Agreement) to hedge the risk of adverse development pertaining to Validus Re’s reserves with Clarendon National Insurance Company (Clarendon), a wholly owned subsidiary of Enstar Group Limited. Under the ADC Agreement, AIG will be reimbursed up to $400 million of adverse development for all policies in force as of December 31, 2022 when paid losses exceed the baseline reserve balance of $3.043 billion. The expected premium to be paid to Clarendon is $80 million.
On November 1, 2023, AIG completed the sale of Validus Re to RenaissanceRe and received $2.7 billion in cash from RenaissanceRe and 1.3 million shares of RenaissanceRe common stock valued at approximately $275 million as of the closing date. The results of Validus Re are reported in General Insurance.
AIG Life Limited
To further simplify Corebridge’s business model, on September 25, 2023, Corebridge announced that it entered into a definitive agreement to sell AIG Life to Aviva plc for £460 million in cash, subject to certain adjustments. The sale of AIG Life is expected to close in the first half of 2024, subject to regulatory approvals and other customary closing conditions. The results of AIG Life are reported in Life and Retirement.
Laya and Other
To further simplify Corebridge’s business model, on August 3, 2023, Corebridge announced that it entered into a definitive agreement to sell its subsidiary, Laya, to AXA for €650 million in cash, subject to certain adjustments. On October 31, 2023, Corebridge completed the sale of Laya to AXA. The results of Laya are reported in Life and Retirement.
Other primarily consists of owner occupied real estate.
The following table summarizes the components of assets and liabilities held-for-sale on the Condensed Consolidated Balance Sheets at September 30, 2023 after elimination of intercompany balances:
(in millions)Validus ReAIG LifeLaya and OtherTotal
Assets:
Bonds available for sale$3,822 $137 $— $3,959 
Other invested assets— — 
Short-term investments, including restricted cash of $262
1,478 32 76 1,586 
Cash176 15 193 
Accrued investment income21 — 24 
Premiums and other receivables, net of allowance for credit losses and disputes3,195 127 15 3,337 
Reinsurance assets - other, net of allowance for credit losses and disputes1,759 794 — 2,553 
Deferred income taxes23 35 59 
Deferred policy acquisition costs623 755 — 1,378 
Other assets, net of allowance for credit losses(a)
676 109 139 924 
Total assets held for sale$11,778 $1,994 $246 $14,018 
Liabilities:
Liability for unpaid losses and loss adjustment expenses, including allowance for credit losses$5,046 $— $— $5,046 
Unearned premiums2,504 71 — 2,575 
Future policy benefits for life and accident and health insurance contracts— 592 — 592 
Other policyholder funds— — 40 40 
Other liabilities910 918 36 1,864 
Total liabilities held for sale$8,460 $1,581 $76 $10,117 
(a)Other assets, net of allowance for credit losses includes goodwill and other intangibles of $318 million and $235 million, respectively, for Validus Re, $23 million and $3 million, respectively, for AIG Life and $30 million and $10 million, respectively, for Laya and other.